Viral Vector Manufacturing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, and Others), Disease Indication (Cancer, Genetic Disorders, Infectious Disease, and Others), Application (Therapeutics Development and Vaccine Development, Research), End User (Pharmaceutical and Biotechnology Companies, CDMOs & CROs, and Research Institutes), and Geography
The viral vector manufacturing market size was valued at US$ 1.74 billion in 2024 and is expected to reach US$ 5.76 billion by 2031; it is estimated to record a CAGR of 18.8% from 2025 to 2031.
The viral vector manufacturing market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. Asia Pacific dominated the market in 2024, followed by Europe and North America, respectively.
Pharmaceutical and biotechnology companies represent a core application segment in the healthcare and life sciences industry. These organizations rely heavily on innovative tools, technologies, and platforms to accelerate drug discovery, development, and commercialization. With increasing pressure to reduce time-to-market and enhance the efficiency of R&D pipelines, companies are investing in advanced analytical tools, high-throughput screening systems, and data-driven platforms. These tools support activities ranging from early-stage target identification to preclinical and clinical evaluations. The growing complexity of diseases, especially in areas like oncology, neurology, and rare diseases, has also fueled the demand for precision medicine, thereby increasing the reliance on genomics, proteomics, and biomarker analysis. Furthermore, regulatory requirements and the need for robust clinical validation drive the adoption of standardized and scalable application solutions. Pharmaceutical and biotech companies are also increasingly collaborating with technology providers and outsourcing partners to gain access to specialized expertise and infrastructure.
Viral vector manufacturing market future trend: The rise of personalized medicine—an approach that customizes medical treatments to individual genetic profiles—is significantly transforming the viral vector manufacturing landscape. Unlike conventional therapies that are developed for broad populations, personalized treatments require highly specific and adaptable delivery mechanisms. Viral vectors, particularly adeno-associated viruses (AAV) and lentiviruses, are at the forefront of this transformation due to their ability to efficiently deliver genetic material with precision and safety.
One of the most prominent examples is in the field of cell and gene therapy, especially in CAR-T (Chimeric Antigen Receptor T-cell) therapies. These involve modifying a patient’s T-cells outside the body using viral vectors, then reintroducing them to combat cancer. Since each treatment is tailored to the individual, the manufacturing of viral vectors must be highly flexible, safe, and reproducible, often in small batches. This has led to an increase in demand for contract development and manufacturing organizations (CDMOs) that can offer specialized, small-scale, GMP-compliant vector production.
Similarly, gene therapies for rare genetic disorders are driving advancements in viral vector capabilities. Treatments such as Zolgensma, used for spinal muscular atrophy, and Luxturna, for inherited retinal disease, rely on AAV vectors to deliver corrective genes directly to affected cells. The success of these therapies has set a new benchmark for precision vector design and production. It also highlights the need for scalable manufacturing that supports high purity and low off-target effects, a requirement that traditional mass-production systems struggle to meet. Another emerging application is in personalized cancer vaccines.
Lonza Group AG; Merck KGaA; Thermo Fisher Scientific Inc., Catalent Inc., Charles River Laboratories International Inc., WuXi AppTec Co Ltd; FUJIFILM Holdings Corp; GenScript Biotech Corporation; Takara Bio Inc., Novartis AG are among the key players profiled during this market study. Several other essential market players were also studied and analyzed to get a holistic view of the global viral vector manufacturing market and its ecosystem.
The overall viral vector manufacturing market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the viral vector manufacturing market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the viral vector manufacturing market.
Reason to buy
The viral vector manufacturing market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. Asia Pacific dominated the market in 2024, followed by Europe and North America, respectively.
Pharmaceutical and biotechnology companies represent a core application segment in the healthcare and life sciences industry. These organizations rely heavily on innovative tools, technologies, and platforms to accelerate drug discovery, development, and commercialization. With increasing pressure to reduce time-to-market and enhance the efficiency of R&D pipelines, companies are investing in advanced analytical tools, high-throughput screening systems, and data-driven platforms. These tools support activities ranging from early-stage target identification to preclinical and clinical evaluations. The growing complexity of diseases, especially in areas like oncology, neurology, and rare diseases, has also fueled the demand for precision medicine, thereby increasing the reliance on genomics, proteomics, and biomarker analysis. Furthermore, regulatory requirements and the need for robust clinical validation drive the adoption of standardized and scalable application solutions. Pharmaceutical and biotech companies are also increasingly collaborating with technology providers and outsourcing partners to gain access to specialized expertise and infrastructure.
Viral vector manufacturing market future trend: The rise of personalized medicine—an approach that customizes medical treatments to individual genetic profiles—is significantly transforming the viral vector manufacturing landscape. Unlike conventional therapies that are developed for broad populations, personalized treatments require highly specific and adaptable delivery mechanisms. Viral vectors, particularly adeno-associated viruses (AAV) and lentiviruses, are at the forefront of this transformation due to their ability to efficiently deliver genetic material with precision and safety.
One of the most prominent examples is in the field of cell and gene therapy, especially in CAR-T (Chimeric Antigen Receptor T-cell) therapies. These involve modifying a patient’s T-cells outside the body using viral vectors, then reintroducing them to combat cancer. Since each treatment is tailored to the individual, the manufacturing of viral vectors must be highly flexible, safe, and reproducible, often in small batches. This has led to an increase in demand for contract development and manufacturing organizations (CDMOs) that can offer specialized, small-scale, GMP-compliant vector production.
Similarly, gene therapies for rare genetic disorders are driving advancements in viral vector capabilities. Treatments such as Zolgensma, used for spinal muscular atrophy, and Luxturna, for inherited retinal disease, rely on AAV vectors to deliver corrective genes directly to affected cells. The success of these therapies has set a new benchmark for precision vector design and production. It also highlights the need for scalable manufacturing that supports high purity and low off-target effects, a requirement that traditional mass-production systems struggle to meet. Another emerging application is in personalized cancer vaccines.
Lonza Group AG; Merck KGaA; Thermo Fisher Scientific Inc., Catalent Inc., Charles River Laboratories International Inc., WuXi AppTec Co Ltd; FUJIFILM Holdings Corp; GenScript Biotech Corporation; Takara Bio Inc., Novartis AG are among the key players profiled during this market study. Several other essential market players were also studied and analyzed to get a holistic view of the global viral vector manufacturing market and its ecosystem.
The overall viral vector manufacturing market size has been derived using both primary and secondary sources. Exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the viral vector manufacturing market size. The process also helps obtain an overview and forecast of the market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain analytical insights. This process includes industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the viral vector manufacturing market.
Reason to buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Viral Vector Manufacturing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global Viral Vector Manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global Viral Vector Manufacturing market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
- Lonza Group AG
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Catalent Inc.
- Charles River Laboratories International Inc.
- WuXi AppTec Co Ltd
- FUJIFILM Holdings Corp
- GenScript Biotech Corporation
- Takara Bio Inc.
- Novartis AG
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. VIRAL VECTOR MANUFACTURING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers:
4.3.2 Vector Design and Development:
4.3.3 Contract Development and Manufacturing Organizations (CDMOs):
4.3.4 End Users:
4.3.5 List of Vendors in the Value Chain
5. VIRAL VECTOR MANUFACTURING MARKET – KEY MARKET DYNAMICS
5.1 Viral Vector Manufacturing Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Demand for Gene and Cell Therapies
5.2.2 Growing Pipeline of Viral Vector-Based Clinical Trials
5.2.3 Rising Government and Private Investment in Advanced Therapies
5.3 Market Restraints
5.3.1 Sensitivity to Raw Material and Supply Chain Fluctuations
5.3.2 Limited Skilled Workforce and Infrastructure
5.4 Market Opportunities
5.4.1 Expansion of Gene Editing Technologies
5.4.2 Emergence of Viral Vector Manufacturing Outsourcing Services
5.4.3 Government Initiatives and Funding
5.5 Future Trends
5.5.1 Technological Advancements in Vector Manufacturing
5.5.2 Government Investments in Biotech Infrastructure
5.5.3 Growth in Personalized Medicine
5.6 Impact of Drivers and Restraints:
6. VIRAL VECTOR MANUFACTURING MARKET – GLOBAL MARKET ANALYSIS
6.1 Viral Vector Manufacturing Market Revenue (US$ Million), 2021–2031
6.2 Viral Vector Manufacturing Market Forecast Analysis
7. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY TYPE
7.1 Adenoviral Vectors
7.1.1 Overview
7.1.2 Adenoviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Adeno-Associated Viral Vectors
7.2.1 Overview
7.2.2 Adeno-Associated Viral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Lentiviral Vectors
7.3.1 Overview
7.3.2 Lentiviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Retroviral Vectors
7.4.1 Overview
7.4.2 Retroviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY DISEASE INDICATION
8.1 Cancer
8.1.1 Overview
8.1.2 Cancer: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Genetic Disorders
8.2.1 Overview
8.2.2 Genetic Disorders: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
9. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY APPLICATION
9.1 Therapeutics Development
9.1.1 Overview
9.1.2 Therapeutics Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Vaccine Development
9.2.1 Overview
9.2.2 Vaccine Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Research
9.3.1 Overview
9.3.2 Research: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
10. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
10.2 CDMOs and CROs
10.2.1 Overview
10.2.2 CDMOs and CROs: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Research Institutes
10.3.1 Overview
10.3.2 Research Institutes: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
11. VIRAL VECTOR MANUFACTURING MARKET – GEOGRAPHICAL ANALYSIS
11.1 Overview
11.2 North America
11.2.1 North America Viral Vector Manufacturing Market Overview
11.2.2 North America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.2.3 North America: Viral Vector Manufacturing Market Breakdown, by Type
11.2.3.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.2.4 North America: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.4.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.2.5 North America: Viral Vector Manufacturing Market Breakdown, by Application
11.2.5.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.2.6 North America: Viral Vector Manufacturing Market Breakdown, by End User
11.2.6.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.2.7 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.2.7.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.2.7.2 United States: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.2.1 United States: Viral Vector Manufacturing Market Breakdown, by Type
11.2.7.2.2 United States: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.7.2.3 United States: Viral Vector Manufacturing Market Breakdown, by Application
11.2.7.2.4 United States: Viral Vector Manufacturing Market Breakdown, by End User
11.2.7.3 Canada: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.3.1 Canada: Viral Vector Manufacturing Market Breakdown, by Type
11.2.7.3.2 Canada: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.7.3.3 Canada: Viral Vector Manufacturing Market Breakdown, by Application
11.2.7.3.4 Canada: Viral Vector Manufacturing Market Breakdown, by End User
11.2.7.4 Mexico: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.4.1 Mexico: Viral Vector Manufacturing Market Breakdown, by Type
11.2.7.4.2 Mexico: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.7.4.3 Mexico: Viral Vector Manufacturing Market Breakdown, by Application
11.2.7.4.4 Mexico: Viral Vector Manufacturing Market Breakdown, by End User
11.3 Europe
11.3.1 Europe Viral Vector Manufacturing Market Overview
11.3.2 Europe: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.3.3 Europe: Viral Vector Manufacturing Market Breakdown, by Type
11.3.3.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.3.4 Europe: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.4.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.3.5 Europe: Viral Vector Manufacturing Market Breakdown, by Application
11.3.5.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.3.6 Europe: Viral Vector Manufacturing Market Breakdown, by End User
11.3.6.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.3.7 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.3.7.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.3.7.2 Germany: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.2.1 Germany: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.2.2 Germany: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.2.3 Germany: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.2.4 Germany: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.3 United Kingdom: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.3.1 United Kingdom: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.3.2 United Kingdom: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.3.3 United Kingdom: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.3.4 United Kingdom: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.4 France: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.4.1 France: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.4.2 France: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.4.3 France: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.4.4 France: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.5 Italy: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.5.1 Italy: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.5.2 Italy: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.5.3 Italy: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.5.4 Italy: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.6 Spain: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.6.1 Spain: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.6.2 Spain: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.6.3 Spain: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.6.4 Spain: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.7 Rest of Europe: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.7.2 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.7.3 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.7.4 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by End User
11.4 Asia Pacific
11.4.1 Asia Pacific Viral Vector Manufacturing Market Overview
11.4.2 Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.4.3 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Type
11.4.3.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.4.4 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.4.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.4.5 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Application
11.4.5.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.4.6 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by End User
11.4.6.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.4.7 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.4.7.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.4.7.2 China: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.2.1 China: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.2.2 China: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.2.3 China: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.2.4 China: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.3 Japan: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.3.1 Japan: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.3.2 Japan: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.3.3 Japan: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.3.4 Japan: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.4 India: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.4.1 India: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.4.2 India: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.4.3 India: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.4.4 India: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.5 Australia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.5.1 Australia: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.5.2 Australia: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.5.3 Australia: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.5.4 Australia: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.6 South Korea: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.6.1 South Korea: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.6.2 South Korea: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.6.3 South Korea: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.6.4 South Korea: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.7 Rest of APAC: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.7.2 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.7.3 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.7.4 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by End User
11.5 Middle East and Africa
11.5.1 Middle East and Africa Viral Vector Manufacturing Market Overview
11.5.2 Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.5.3 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Type
11.5.3.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.5.4 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.4.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.5.5 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Application
11.5.5.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.5.6 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by End User
11.5.6.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.5.7 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.5.7.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.5.7.2 Saudi Arabia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.2.1 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.2.2 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.2.3 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.2.4 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by End User
11.5.7.3 South Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.3.1 South Africa: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.3.2 South Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.3.3 South Africa: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.3.4 South Africa: Viral Vector Manufacturing Market Breakdown, by End User
11.5.7.4 United Arab Emirates: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.4.2 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.4.3 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.4.4 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by End User
11.5.7.5 Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.5.2 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.5.3 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.5.4 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by End User
11.6 South and Central America
11.6.1 South and Central America Viral Vector Manufacturing Market Overview
11.6.2 South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.6.3 South and Central America: Viral Vector Manufacturing Market Breakdown, by Type
11.6.3.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.6.4 South and Central America: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.4.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.6.5 South and Central America: Viral Vector Manufacturing Market Breakdown, by Application
11.6.5.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.6.6 South and Central America: Viral Vector Manufacturing Market Breakdown, by End User
11.6.6.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.6.7 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.6.7.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.6.7.2 Brazil: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.2.1 Brazil: Viral Vector Manufacturing Market Breakdown, by Type
11.6.7.2.2 Brazil: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.7.2.3 Brazil: Viral Vector Manufacturing Market Breakdown, by Application
11.6.7.2.4 Brazil: Viral Vector Manufacturing Market Breakdown, by End User
11.6.7.3 Argentina: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.3.1 Argentina: Viral Vector Manufacturing Market Breakdown, by Type
11.6.7.3.2 Argentina: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.7.3.3 Argentina: Viral Vector Manufacturing Market Breakdown, by Application
11.6.7.3.4 Argentina: Viral Vector Manufacturing Market Breakdown, by End User
11.6.7.4 Rest of South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by Type
11.6.7.4.2 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.7.4.3 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by Application
11.6.7.4.4 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by End User
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. INDUSTRY LANDSCAPE
13.1 Overview
13.2 Market Initiative
13.3 Merger and Acquisition
13.4 Other Developments
14. COMPANY PROFILES
14.1 Lonza Group AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Catalent Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Charles River Laboratories International Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 FUJIFILM Holdings Corp
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 GenScript Biotech Corporation
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Takara Bio Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Novartis AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
15.2 List of Abbreviations
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Analyst Market Outlook
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 Assumptions and Limitations
4. VIRAL VECTOR MANUFACTURING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers:
4.3.2 Vector Design and Development:
4.3.3 Contract Development and Manufacturing Organizations (CDMOs):
4.3.4 End Users:
4.3.5 List of Vendors in the Value Chain
5. VIRAL VECTOR MANUFACTURING MARKET – KEY MARKET DYNAMICS
5.1 Viral Vector Manufacturing Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Demand for Gene and Cell Therapies
5.2.2 Growing Pipeline of Viral Vector-Based Clinical Trials
5.2.3 Rising Government and Private Investment in Advanced Therapies
5.3 Market Restraints
5.3.1 Sensitivity to Raw Material and Supply Chain Fluctuations
5.3.2 Limited Skilled Workforce and Infrastructure
5.4 Market Opportunities
5.4.1 Expansion of Gene Editing Technologies
5.4.2 Emergence of Viral Vector Manufacturing Outsourcing Services
5.4.3 Government Initiatives and Funding
5.5 Future Trends
5.5.1 Technological Advancements in Vector Manufacturing
5.5.2 Government Investments in Biotech Infrastructure
5.5.3 Growth in Personalized Medicine
5.6 Impact of Drivers and Restraints:
6. VIRAL VECTOR MANUFACTURING MARKET – GLOBAL MARKET ANALYSIS
6.1 Viral Vector Manufacturing Market Revenue (US$ Million), 2021–2031
6.2 Viral Vector Manufacturing Market Forecast Analysis
7. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY TYPE
7.1 Adenoviral Vectors
7.1.1 Overview
7.1.2 Adenoviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Adeno-Associated Viral Vectors
7.2.1 Overview
7.2.2 Adeno-Associated Viral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Lentiviral Vectors
7.3.1 Overview
7.3.2 Lentiviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Retroviral Vectors
7.4.1 Overview
7.4.2 Retroviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY DISEASE INDICATION
8.1 Cancer
8.1.1 Overview
8.1.2 Cancer: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Genetic Disorders
8.2.1 Overview
8.2.2 Genetic Disorders: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
9. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY APPLICATION
9.1 Therapeutics Development
9.1.1 Overview
9.1.2 Therapeutics Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Vaccine Development
9.2.1 Overview
9.2.2 Vaccine Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Research
9.3.1 Overview
9.3.2 Research: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
10. VIRAL VECTOR MANUFACTURING MARKET ANALYSIS – BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
10.2 CDMOs and CROs
10.2.1 Overview
10.2.2 CDMOs and CROs: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Research Institutes
10.3.1 Overview
10.3.2 Research Institutes: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
11. VIRAL VECTOR MANUFACTURING MARKET – GEOGRAPHICAL ANALYSIS
11.1 Overview
11.2 North America
11.2.1 North America Viral Vector Manufacturing Market Overview
11.2.2 North America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.2.3 North America: Viral Vector Manufacturing Market Breakdown, by Type
11.2.3.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.2.4 North America: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.4.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.2.5 North America: Viral Vector Manufacturing Market Breakdown, by Application
11.2.5.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.2.6 North America: Viral Vector Manufacturing Market Breakdown, by End User
11.2.6.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.2.7 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.2.7.1 North America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.2.7.2 United States: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.2.1 United States: Viral Vector Manufacturing Market Breakdown, by Type
11.2.7.2.2 United States: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.7.2.3 United States: Viral Vector Manufacturing Market Breakdown, by Application
11.2.7.2.4 United States: Viral Vector Manufacturing Market Breakdown, by End User
11.2.7.3 Canada: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.3.1 Canada: Viral Vector Manufacturing Market Breakdown, by Type
11.2.7.3.2 Canada: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.7.3.3 Canada: Viral Vector Manufacturing Market Breakdown, by Application
11.2.7.3.4 Canada: Viral Vector Manufacturing Market Breakdown, by End User
11.2.7.4 Mexico: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.2.7.4.1 Mexico: Viral Vector Manufacturing Market Breakdown, by Type
11.2.7.4.2 Mexico: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.2.7.4.3 Mexico: Viral Vector Manufacturing Market Breakdown, by Application
11.2.7.4.4 Mexico: Viral Vector Manufacturing Market Breakdown, by End User
11.3 Europe
11.3.1 Europe Viral Vector Manufacturing Market Overview
11.3.2 Europe: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.3.3 Europe: Viral Vector Manufacturing Market Breakdown, by Type
11.3.3.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.3.4 Europe: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.4.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.3.5 Europe: Viral Vector Manufacturing Market Breakdown, by Application
11.3.5.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.3.6 Europe: Viral Vector Manufacturing Market Breakdown, by End User
11.3.6.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.3.7 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.3.7.1 Europe: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.3.7.2 Germany: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.2.1 Germany: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.2.2 Germany: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.2.3 Germany: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.2.4 Germany: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.3 United Kingdom: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.3.1 United Kingdom: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.3.2 United Kingdom: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.3.3 United Kingdom: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.3.4 United Kingdom: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.4 France: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.4.1 France: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.4.2 France: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.4.3 France: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.4.4 France: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.5 Italy: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.5.1 Italy: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.5.2 Italy: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.5.3 Italy: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.5.4 Italy: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.6 Spain: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.6.1 Spain: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.6.2 Spain: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.6.3 Spain: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.6.4 Spain: Viral Vector Manufacturing Market Breakdown, by End User
11.3.7.7 Rest of Europe: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.3.7.7.1 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by Type
11.3.7.7.2 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.3.7.7.3 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by Application
11.3.7.7.4 Rest of Europe: Viral Vector Manufacturing Market Breakdown, by End User
11.4 Asia Pacific
11.4.1 Asia Pacific Viral Vector Manufacturing Market Overview
11.4.2 Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.4.3 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Type
11.4.3.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.4.4 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.4.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.4.5 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Application
11.4.5.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.4.6 Asia Pacific: Viral Vector Manufacturing Market Breakdown, by End User
11.4.6.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.4.7 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.4.7.1 Asia Pacific: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.4.7.2 China: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.2.1 China: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.2.2 China: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.2.3 China: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.2.4 China: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.3 Japan: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.3.1 Japan: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.3.2 Japan: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.3.3 Japan: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.3.4 Japan: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.4 India: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.4.1 India: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.4.2 India: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.4.3 India: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.4.4 India: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.5 Australia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.5.1 Australia: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.5.2 Australia: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.5.3 Australia: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.5.4 Australia: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.6 South Korea: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.6.1 South Korea: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.6.2 South Korea: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.6.3 South Korea: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.6.4 South Korea: Viral Vector Manufacturing Market Breakdown, by End User
11.4.7.7 Rest of APAC: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.4.7.7.1 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by Type
11.4.7.7.2 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.4.7.7.3 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by Application
11.4.7.7.4 Rest of APAC: Viral Vector Manufacturing Market Breakdown, by End User
11.5 Middle East and Africa
11.5.1 Middle East and Africa Viral Vector Manufacturing Market Overview
11.5.2 Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.5.3 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Type
11.5.3.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.5.4 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.4.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.5.5 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Application
11.5.5.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.5.6 Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by End User
11.5.6.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.5.7 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.5.7.1 Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.5.7.2 Saudi Arabia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.2.1 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.2.2 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.2.3 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.2.4 Saudi Arabia: Viral Vector Manufacturing Market Breakdown, by End User
11.5.7.3 South Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.3.1 South Africa: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.3.2 South Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.3.3 South Africa: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.3.4 South Africa: Viral Vector Manufacturing Market Breakdown, by End User
11.5.7.4 United Arab Emirates: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.4.1 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.4.2 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.4.3 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.4.4 United Arab Emirates: Viral Vector Manufacturing Market Breakdown, by End User
11.5.7.5 Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.5.7.5.1 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Type
11.5.7.5.2 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.5.7.5.3 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Application
11.5.7.5.4 Rest of Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by End User
11.6 South and Central America
11.6.1 South and Central America Viral Vector Manufacturing Market Overview
11.6.2 South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
11.6.3 South and Central America: Viral Vector Manufacturing Market Breakdown, by Type
11.6.3.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Type
11.6.4 South and Central America: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.4.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Disease Indication
11.6.5 South and Central America: Viral Vector Manufacturing Market Breakdown, by Application
11.6.5.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Application
11.6.6 South and Central America: Viral Vector Manufacturing Market Breakdown, by End User
11.6.6.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by End User
11.6.7 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.6.7.1 South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast Analysis – by Country
11.6.7.2 Brazil: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.2.1 Brazil: Viral Vector Manufacturing Market Breakdown, by Type
11.6.7.2.2 Brazil: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.7.2.3 Brazil: Viral Vector Manufacturing Market Breakdown, by Application
11.6.7.2.4 Brazil: Viral Vector Manufacturing Market Breakdown, by End User
11.6.7.3 Argentina: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.3.1 Argentina: Viral Vector Manufacturing Market Breakdown, by Type
11.6.7.3.2 Argentina: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.7.3.3 Argentina: Viral Vector Manufacturing Market Breakdown, by Application
11.6.7.3.4 Argentina: Viral Vector Manufacturing Market Breakdown, by End User
11.6.7.4 Rest of South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
11.6.7.4.1 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by Type
11.6.7.4.2 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by Disease Indication
11.6.7.4.3 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by Application
11.6.7.4.4 Rest of South and Central America: Viral Vector Manufacturing Market Breakdown, by End User
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Market Share Analysis, 2024
13. INDUSTRY LANDSCAPE
13.1 Overview
13.2 Market Initiative
13.3 Merger and Acquisition
13.4 Other Developments
14. COMPANY PROFILES
14.1 Lonza Group AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Catalent Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Charles River Laboratories International Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 FUJIFILM Holdings Corp
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 GenScript Biotech Corporation
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Takara Bio Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Novartis AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. APPENDIX
15.1 About The Insight Partners
15.2 List of Abbreviations
LIST OF TABLES
Table 1. Viral Vector Manufacturing Market Segmentation
Table 2. List of Vendors
Table 3. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million)
Table 4. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 5. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 6. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 7. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 8. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 9. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 10. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 11. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 12. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 13. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 14. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 15. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 16. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 17. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 18. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 19. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 20. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 21. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 22. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 23. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 24. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 25. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 26. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 27. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 28. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 29. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 30. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 31. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 32. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 33. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 34. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 35. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 36. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 37. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 38. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 39. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 40. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 41. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 42. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 43. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 44. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 45. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 46. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 47. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 48. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 49. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 50. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 51. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 52. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 53. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 54. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 55. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 56. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 57. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 58. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 59. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 60. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 61. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 62. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 63. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 64. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 65. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 66. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 67. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 68. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 69. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 70. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 71. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 72. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 73. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 74. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 75. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 76. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 77. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 78. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 79. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 80. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 81. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 82. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 83. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 84. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 85. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 86. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 87. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 88. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 89. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 90. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 91. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 92. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 93. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 94. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 95. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 96. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 97. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 98. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 99. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 100. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 101. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 102. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 103. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 104. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 105. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 106. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 107. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 108. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 109. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 110. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 111. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 112. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 113. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 114. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 115. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 116. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 117. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 118. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 119. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 120. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 121. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 122. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 123. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 124. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 125. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 126. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 127. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 128. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 129. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 130. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 131. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 132. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 133. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 134. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 135. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 136. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 137. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 138. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 139. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 140. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 141. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 142. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 143. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 144. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 145. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 146. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 147. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 148. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 149. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 150. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 151. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 152. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 153. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 154. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 155. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 156. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 157. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 158. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 159. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 160. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 161. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 162. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 163. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 164. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 165. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 166. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 167. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 168. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 169. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 170. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 171. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 172. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 173. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 174. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 175. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 176. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 177. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 178. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 179. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 180. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 181. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 182. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 183. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 184. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 185. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 186. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 187. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 188. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 189. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 190. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 191. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 192. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 193. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 194. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 195. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 196. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 197. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 198. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 199. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 200. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 201. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 202. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 203. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 204. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 205. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 206. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 207. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 208. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 209. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 210. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 211. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 212. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 213. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 214. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 215. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 216. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 217. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 218. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 219. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 220. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 221. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 222. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 223. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 224. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 225. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 226. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 227. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 228. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 229. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 230. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 231. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 232. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 233. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 234. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 235. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 236. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 237. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 238. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 239. Heat Map Analysis by Key Players
Table 240. List of Abbreviations
Table 1. Viral Vector Manufacturing Market Segmentation
Table 2. List of Vendors
Table 3. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million)
Table 4. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million)
Table 5. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 6. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 7. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 8. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 9. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 10. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 11. Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 12. Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 13. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 14. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 15. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 16. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 17. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 18. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 19. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 20. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 21. North America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 22. North America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 23. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 24. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 25. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 26. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 27. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 28. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 29. United States: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 30. United States: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 31. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 32. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 33. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 34. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 35. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 36. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 37. Canada: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 38. Canada: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 39. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 40. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 41. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 42. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 43. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 44. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 45. Mexico: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 46. Mexico: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 47. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 48. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 49. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 50. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 51. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 52. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 53. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 54. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 55. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 56. Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 57. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 58. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 59. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 60. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 61. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 62. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 63. Germany: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 64. Germany: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 65. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 66. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 67. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 68. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 69. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 70. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 71. United Kingdom: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 72. United Kingdom: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 73. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 74. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 75. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 76. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 77. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 78. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 79. France: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 80. France: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 81. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 82. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 83. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 84. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 85. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 86. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 87. Italy: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 88. Italy: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 89. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 90. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 91. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 92. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 93. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 94. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 95. Spain: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 96. Spain: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 97. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 98. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 99. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 100. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 101. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 102. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 103. Rest of Europe: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 104. Rest of Europe: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 105. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 106. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 107. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 108. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 109. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 110. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 111. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 112. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 113. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 114. Asia Pacific: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 115. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 116. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 117. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 118. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 119. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 120. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 121. China: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 122. China: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 123. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 124. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 125. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 126. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 127. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 128. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 129. Japan: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 130. Japan: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 131. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 132. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 133. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 134. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 135. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 136. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 137. India: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 138. India: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 139. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 140. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 141. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 142. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 143. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 144. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 145. Australia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 146. Australia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 147. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 148. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 149. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 150. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 151. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 152. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 153. South Korea: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 154. South Korea: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 155. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 156. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 157. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 158. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 159. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 160. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 161. Rest of APAC: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 162. Rest of APAC: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 163. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 164. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 165. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 166. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 167. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 168. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 169. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 170. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 171. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 172. Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 173. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 174. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 175. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 176. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 177. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 178. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 179. Saudi Arabia: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 180. Saudi Arabia: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 181. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 182. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 183. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 184. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 185. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 186. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 187. South Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 188. South Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 189. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 190. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 191. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 192. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 193. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 194. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 195. United Arab Emirates: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 196. United Arab Emirates: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 197. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 198. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 199. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 200. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 201. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 202. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 203. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 204. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 205. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 206. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 207. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 208. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 209. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 210. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 211. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 212. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 213. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Country
Table 214. South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country
Table 215. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 216. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 217. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 218. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 219. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 220. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 221. Brazil: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 222. Brazil: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 223. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 224. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 225. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 226. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 227. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 228. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 229. Argentina: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 230. Argentina: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 231. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Type
Table 232. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Type
Table 233. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Disease Indication
Table 234. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Disease Indication
Table 235. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by Application
Table 236. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by Application
Table 237. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2024 (US$ Million) – by End User
Table 238. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue Forecast, 2025–2031 (US$ Million) – by End User
Table 239. Heat Map Analysis by Key Players
Table 240. List of Abbreviations
LIST OF FIGURES
Figure 1. Viral Vector Manufacturing Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Viral Vector Manufacturing Market Revenue (US$ Million), 2021–2031
Figure 5. Viral Vector Manufacturing Market Share (%) – by Type (2024 and 2031)
Figure 6. Adenoviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Adeno-Associated Viral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Lentiviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Retroviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Viral Vector Manufacturing Market Share (%) – by Disease Indication (2024 and 2031)
Figure 12. Cancer: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Genetic Disorders: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Infectious Diseases: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Viral Vector Manufacturing Market Share (%) – by Application (2024 and 2031)
Figure 17. Therapeutics Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Vaccine Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Research: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Viral Vector Manufacturing Market Share (%) – by End User (2024 and 2031)
Figure 21. Pharmaceutical and Biotechnology Companies: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. CDMOs and CROs: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Research Institutes: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Viral Vector Manufacturing Market Breakdown by Region, 2024 and 2031 (%)
Figure 25. North America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 26. North America: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 27. North America: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 28. North America: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 29. North America: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 30. North America: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. United States: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 32. Canada: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 33. Mexico: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 34. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 35. Europe: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 36. Europe: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 37. Europe: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 38. Europe: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 39. Europe: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 40. Germany: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 41. United Kingdom: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 42. France: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 43. Italy: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 44. Spain: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 45. Rest of Europe: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 46. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 47. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 48. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 49. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 50. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 51. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 52. China: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 53. Japan: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 54. India: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 55. Australia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 56. South Korea: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 57. Rest of APAC: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 58. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 59. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 60. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 61. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 62. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 63. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 64. Saudi Arabia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 65. South Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 66. United Arab Emirates: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 67. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 68. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 69. South and Central America: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 70. South and Central America: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 71. South and Central America: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 72. South and Central America: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 73. South and Central America: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 74. Brazil: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 75. Argentina: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 76. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 77. Company Market Share Analysis, 2024
Figure 1. Viral Vector Manufacturing Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Viral Vector Manufacturing Market Revenue (US$ Million), 2021–2031
Figure 5. Viral Vector Manufacturing Market Share (%) – by Type (2024 and 2031)
Figure 6. Adenoviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Adeno-Associated Viral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Lentiviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Retroviral Vectors: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Viral Vector Manufacturing Market Share (%) – by Disease Indication (2024 and 2031)
Figure 12. Cancer: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Genetic Disorders: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Infectious Diseases: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Viral Vector Manufacturing Market Share (%) – by Application (2024 and 2031)
Figure 17. Therapeutics Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Vaccine Development: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Research: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Viral Vector Manufacturing Market Share (%) – by End User (2024 and 2031)
Figure 21. Pharmaceutical and Biotechnology Companies: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. CDMOs and CROs: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Research Institutes: Viral Vector Manufacturing Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Viral Vector Manufacturing Market Breakdown by Region, 2024 and 2031 (%)
Figure 25. North America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 26. North America: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 27. North America: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 28. North America: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 29. North America: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 30. North America: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 31. United States: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 32. Canada: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 33. Mexico: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 34. Europe: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 35. Europe: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 36. Europe: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 37. Europe: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 38. Europe: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 39. Europe: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 40. Germany: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 41. United Kingdom: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 42. France: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 43. Italy: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 44. Spain: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 45. Rest of Europe: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 46. Asia Pacific: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 47. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 48. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 49. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 50. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 51. Asia Pacific: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 52. China: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 53. Japan: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 54. India: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 55. Australia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 56. South Korea: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 57. Rest of APAC: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 58. Middle East and Africa: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 59. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 60. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 61. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 62. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 63. Middle East and Africa: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 64. Saudi Arabia: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 65. South Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 66. United Arab Emirates: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 67. Rest of Middle East and Africa: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 68. South and Central America: Viral Vector Manufacturing Market – Revenue, 2021–2031 (US$ Million)
Figure 69. South and Central America: Viral Vector Manufacturing Market Breakdown, by Type (2024 and 2031)
Figure 70. South and Central America: Viral Vector Manufacturing Market Breakdown, by Disease Indication (2024 and 2031)
Figure 71. South and Central America: Viral Vector Manufacturing Market Breakdown, by Application (2024 and 2031)
Figure 72. South and Central America: Viral Vector Manufacturing Market Breakdown, by End User (2024 and 2031)
Figure 73. South and Central America: Viral Vector Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
Figure 74. Brazil: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 75. Argentina: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 76. Rest of South and Central America: Viral Vector Manufacturing Market – Revenue and Forecast, 2021–2031 (US$ Million)
Figure 77. Company Market Share Analysis, 2024
